BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 103 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,947,600 | +0.6% | 1,970,000 | 0.0% | 0.25% | +7.3% |
| Q2 2023 | $13,868,800 | +50.8% | 1,970,000 | +78.6% | 0.23% | +38.5% |
| Q1 2023 | $9,198,094 | +8.9% | 1,102,889 | +5.3% | 0.17% | -54.8% |
| Q4 2018 | $8,449,000 | +5.8% | 1,047,000 | 0.0% | 0.37% | +27.6% |
| Q3 2018 | $7,989,000 | +461.0% | 1,047,000 | +261.0% | 0.29% | +295.9% |
| Q4 2017 | $1,424,000 | -6.3% | 290,000 | 0.0% | 0.07% | -14.0% |
| Q3 2017 | $1,520,000 | -5.7% | 290,000 | 0.0% | 0.09% | -14.0% |
| Q2 2017 | $1,612,000 | – | 290,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 864,916 | $13,674,000 | 13.71% |
| Sarissa Capital Management LP | 4,261,000 | $67,366,000 | 5.36% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,920,733 | $30,367,000 | 4.18% |
| HealthCor Management, L.P. | 3,248,100 | $51,352,000 | 2.05% |
| Parkman Healthcare Partners LLC | 351,961 | $5,565,000 | 1.22% |
| Bain Capital Public Equity Management II, LLC | 1,560,730 | $24,675,000 | 1.06% |
| Baker Brothers Advisors | 12,710,818 | $200,958,000 | 0.88% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,835,000 | $44,821,000 | 0.80% |
| Biondo Investment Advisors, LLC | 265,840 | $4,203,000 | 0.72% |
| EAM Global Investors LLC | 157,065 | $2,483,000 | 0.69% |